Identification |
Name: | N~2~-[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]-N-(2-methyl-4-oxoquinazolin-3(4H)-yl)glycinamide |
Synonyms: | BRN 4339009;1,3,4-Oxadiazole-2-acetamide, 2-(p-bromophenyl)-N-(2-methyl-4-oxo-3(4H)-quinazolinyl)-;Acetamide, 2-((5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl)amino)-N-(2-methyl-4-oxo-3(4H)-quinazolinyl)-;AC1MIQJI;LS-8353;135790-31-7;2-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]amino]-N-(2-methyl-4-oxoquinazolin-3-yl)acetamide |
CAS: | 135790-31-7 |
Molecular Formula: | C19H15BrN6O3 |
Molecular Weight: | 455.2648 |
InChI: | InChI=1/C19H15BrN6O3/c1-11-22-15-5-3-2-4-14(15)18(28)26(11)25-16(27)10-21-19-24-23-17(29-19)12-6-8-13(20)9-7-12/h2-9H,10H2,1H3,(H,21,24)(H,25,27) |
Molecular Structure: |
|
Properties |
Flash Point: | °C |
Boiling Point: | °Cat760mmHg |
Density: | 1.67g/cm3 |
Refractive index: | 1.741 |
Flash Point: | °C |
Safety Data |
|
|